Figure 2 Blockade of immune checkpoint inhibitors. Engagement of CTLA-4 with its ligands CD80/CD86 can prevent the ligands binding to the T-cell activation and proliferation. Engagement of PD-1 with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback